
Pioneering AI Drug Discovery | Recursion
Our data and the Recursion OS enable us to train intelligent machine learning models for AI drug discovery and development, which help us rapidly identify new targets and design highly …
Recursion Pharmaceuticals, Inc. - Recursion to Report Third …
Oct 28, 2025 · Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New …
Our TechBio Mindset | Recursion
The recursion mindset is the deep belief and commitment to industrializing drug discovery through automation, algorithms, and data to deliver on our mission. This is made manifest through our …
Najat Khan, Ph.D. - Recursion
At Recursion, Dr. Khan has combined bold vision with disciplined leadership to advance value and impact.
Our Unique Approach to AI Drug Discovery | Recursion
Unlike traditional drug discovery, which begins with a specific target or hypothesis, we leverage the Recursion OS — our drug discovery and development platform for AI in pharma connects …
How a First-of-its-Kind “Microglia Map” from Recursion and Roche …
Oct 29, 2025 · A first-of-its-kind whole genome map from researchers at Recursion with partners Roche and Genentech offers a new approach to exploring novel targets and pathways for a …
Careers at Recursion: Join Our Mission | Recursion
Embark on a career journey with Recursion. Dive into opportunities, culture, and the impact you can make. Apply to work with us today!
Ben Taylor - recursion.com
Ben Taylor comes to Recursion after over 4 years as the CFO of Exscientia. Ben has more than two decades of experience in healthcare investment banking and executive roles, including 15 …
Recursion's Drug Discovery Pipeline | Recursion
Leveraging the power of the Recursion OS, we are building an industry-leading pipeline of potential best-in-class and first-in-class therapeutic assets. We focus on indications with high …
AI-Driven Drug Discovery Insights | Recursion
Oct 29, 2025 · Explore Recursion's latest blog posts on AI, automation, and molecular modeling in drug discovery. Stay informed with cutting-edge insights!